Total Funding
48
49
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
-25 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
111961
Calosyn Pharma focuses on developing innovative treatments for osteoarthritis.
David Waddell: Founder
Ross Barrett: Director
About the Company
Calosyn Pharma focuses on developing innovative treatments for osteoarthritis. Its product, CAL-05CR, is a sustained-release injectable therapy that combines verapamil with a biodegradable delivery system. This treatment is designed to provide long-lasting pain relief and reduce inflammation by targeting the underlying causes of osteoarthritis,
such as abnormal calcium ion channel signaling.
